Advanced search
Publication Cover
Current Medical Research and Opinion Volume 25, 2009 - Issue 4
Submit an article Journal homepage
199
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Estimating the prevalence and economic burden of overactive bladder among Medicare beneficiaries prior to Medicare Part D coverage

Miriam G. Cisternas MGC Data Services, Carlsbad, CA, USA
,
Aimee J. Foreman ICON Clinical Research, San Francisco, CA, USACorrespondence[email protected]
,
Thomas S. Marshall Astellas Pharma US, Inc., Deerfield, IL, USA
,
M. Chris Runken GlaxoSmithKline, Inc, Research Triangle Park, NC, USA
,
Kathleen C. Kobashi Virginia Mason Medical Center, Seattle, WA, USA
&
Raafat Seifeldin Astellas Pharma US, Inc., Deerfield, IL, USA
Pages 911-919 | Accepted 02 Feb 2009, Published online: 27 Feb 2009

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Michael L. Ganz, Jieruo Liu, Kelly H. Zou, Tarun Bhagnani & Xuemei Luo. (2016) Real-world characteristics of elderly patients with overactive bladder in the United States. Current Medical Research and Opinion 32:12, pages 1997-2005.
Read now
Umberto Leone Roberti Maggiore, Linda Cardozo, Simone Ferrero, Filomena Sileo, Alice Cola, Marco Torella, Nicola Colacurci, Massimo Candiani & Stefano Salvatore. (2014) Mirabegron in the treatment of overactive bladder. Expert Opinion on Pharmacotherapy 15:6, pages 873-887.
Read now
Jerilyn M Latini & Antonella Giannantoni. (2011) Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder. Expert Opinion on Pharmacotherapy 12:7, pages 1017-1027.
Read now
Pradeep Tyagi, Vikas Tyagi & Michael Chancellor. (2011) Mirabegron: a safety review. Expert Opinion on Drug Safety 10:2, pages 287-294.
Read now

Articles from other publishers (18)

Lindsay M. Allen, Chelsea Nalley, Alison R. Devries & Steve R. Fisher. (2023) Efficacy of Behavioral Interventions for Urinary Incontinence Among Women Residing in Nursing Homes. Journal of Wound, Ostomy & Continence Nursing 50:1, pages 57-65.
Crossref
Noll L. Campbell, Lisa Hines, Andrew J. Epstein, David Walker, Amy Lockefeer & Aki Shiozawa. (2021) A 12-Year Retrospective Study of the Prevalence of Anticholinergic Polypharmacy and Associated Outcomes Among Medicare Patients with Overactive Bladder in the USA. Drugs & Aging 38:12, pages 1075-1085.
Crossref
Arthur L. Burnett, David R. Walker, Qi Feng, Karissa M. Johnston, Greta Lozano‐Ortega, David Nimke & John C. Hairston. (2020) Undertreatment of overactive bladder among men with lower urinary tract symptoms in the United States: A retrospective observational study. Neurourology and Urodynamics 39:5, pages 1378-1386.
Crossref
Greta Lozano-Ortega, Daniel B. Ng, Shelagh M. Szabo, Alison M. Deighton, Bruno Riveros, Anne Guttschow, Katherine L. Gooch & Cristiano M. Gomes. (2020) Management of Patients with Overactive Bladder in Brazil: A Retrospective Observational Study Using Data From the Brazilian Public Health System. Advances in Therapy 37:5, pages 2344-2355.
Crossref
Chien-Chia Chuang, Erru Yang, Kelly H. Zou, Anna Araiza, Alan Wang & Xuemei Luo. (2019) Health and functional status, health events, use of healthcare services and costs associated with overactive bladder among the medically complex vulnerable elderly in the US. International Journal of Clinical Practice 73:8, pages e13207.
Crossref
Gary Puckrein, David Walker, Liou Xu, Peter Congdon & Katherine Gooch. (2019) The Prevalence and Forecast Prevalence of Overactive Bladder in the Medicare Population. Clinical Medicine Insights: Urology 12, pages 117956111984746.
Crossref
Ravishankar Jayadevappa, Sumedha Chhatre, Diane K. Newman, Jerome Sanford Schwartz & Alan J. Wein. (2018) Association between overactive bladder treatment and falls among older adults. Neurourology and Urodynamics 37:8, pages 2688-2694.
Crossref
Lauren C. Powell, Shelagh M. Szabo, David Walker & Katherine Gooch. (2018) The economic burden of overactive bladder in the United States: A systematic literature review. Neurourology and Urodynamics 37:4, pages 1241-1249.
Crossref
Sinem Perk, Ronald C. Wielage, Noll L. Campbell, Timothy M. Klein, Anthony Perkins, Linda M. Posta, Thomas Yuran, Robert W. Klein & Daniel B. Ng. (2016) Estimated Budget Impact of Increased Use of Mirabegron, A Novel Treatment for Overactive Bladder. Journal of Managed Care & Specialty Pharmacy 22:9, pages 1076-1090.
Crossref
Sinem Perk, Ronald C. Wielage, Noll L. Campbell, Timothy M. Klein, Anthony Perkins, Linda M. Posta, Thomas Yuran, Robert W. Klein & Daniel B. Ng. (2016) Estimated Budget Impact of Increased Use of Mirabegron, A Novel Treatment for Overactive Bladder. Journal of Managed Care & Specialty Pharmacy 22:9, pages 1072-1084.
Crossref
Alon Yehoshua, Michael Chancellor, Sandip Vasavada, Daniel C. Malone, Edward P. Armstrong, Manher Joshi, Karen Campbell & Riya Pulicharam. (2016) Health Resource Utilization and Cost for Patients with Incontinent Overactive Bladder Treated with Anticholinergics. Journal of Managed Care & Specialty Pharmacy 22:4, pages 406-413.
Crossref
Dara Faye Shalom, Nirmala Pillalamarri, Xiangying Xue, Nina Kohn, Lawrence Russell Lind, Harvey Allen Winkler & Christine Noel Metz. (2014) Sacral nerve stimulation reduces elevated urinary nerve growth factor levels in women with symptomatic detrusor overactivity. American Journal of Obstetrics and Gynecology 211:5, pages 561.e1-561.e5.
Crossref
Melissa Sanford & Donna Y. Deng. (2013) Economics of Overactive Bladder. Current Bladder Dysfunction Reports 9:1, pages 52-57.
Crossref
Varant Kupelian, Raymond C. Rosen, Claus G. Roehrborn, Pradeep Tyagi, Michael B. Chancellor & John B. McKinlay. (2012) Association of overactive bladder and C-reactive protein levels. Results from the Boston Area Community Health (BACH) Survey. BJU International 110:3, pages 401-407.
Crossref
Stephen R. Kraus, Tamara Bavendam, Tiffany Brake & Tomas L. Griebling. (2010) Vulnerable Elderly Patients and Overactive Bladder Syndrome. Drugs & Aging 27:9, pages 697-713.
Crossref
J. Quentin Clemens. (2010) Afferent Neurourology: An Epidemiological Perspective. Journal of Urology 184:2, pages 432-439.
Crossref
Brian T. Helfand, R. Mark Evans & Kevin T. McVary. (2010) A Comparison of the Frequencies of Medical Therapies for Overactive Bladder in Men and Women: Analysis of More Than 7.2 Million Aging Patients. European Urology 57:4, pages 586-591.
Crossref
Leslee J. Shaw, James K. Min, Matthew Budoff, Heidi Gransar, Alan Rozanski, Sean W. Hayes, John D. Friedman, Romalisa Miranda, Nathan D. Wong & Daniel S. Berman. (2009) Induced Cardiovascular Procedural Costs and Resource Consumption Patterns After Coronary Artery Calcium Screening. Journal of the American College of Cardiology 54:14, pages 1258-1267.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.